Thermo Fisher Scientific Inc. (NYSE:TMO) was highlighted by Jim Cramer for its strong earnings report, noting better than expected results and accelerating organic revenue growth. Although TMO has potential, Cramer favors Danaher (DHR) for its performance in the market. Investors may want to consider other AI stocks for greater potential returns.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides laboratory products, analytical instruments, diagnostics, and biopharma services. Cramer mentioned the impact of COVID-19 on the company, comparing it to Danaher (DHR) and favoring the latter for its current standing. TMO may have room for growth, but other AI stocks could offer better opportunities.

For investors seeking AI stocks with significant upside potential and minimal downside risk, consider exploring other options beyond Thermo Fisher Scientific Inc. (NYSE:TMO). While TMO has its merits, alternative AI stocks may present more attractive investment opportunities. Check out our report on the best short-term AI stock for more insights.

Read more at Yahoo Finance: “Maybe This Stock Can Finally Get its Groove Back”